CLSD icon

Clearside Biomedical

53 hedge funds and large institutions have $121M invested in Clearside Biomedical in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-6
Holders Change %
-10.17%
% of All Funds
1.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
28
Reduced
10
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citigroup
51
Citigroup
New York
$2K -$16.8K -1,852 -89%
Barclays
52
Barclays
United Kingdom
$1K -$1.3K -223 -56%
O
53
OrbiMed
New York
-$2.38M -300,000 Closed
ACP
54
Acuta Capital Partners
California
-$1.39M -175,000 Closed
NC
55
Nexthera Capital
New York
-$959K -120,763 Closed
PP
56
PDT Partners
New York
-$534K -67,300 Closed
Swiss National Bank
57
Swiss National Bank
Switzerland
-$224K -28,200 Closed
AA
58
ALPS Advisors
Colorado
-$168K -21,116 Closed
Millennium Management
59
Millennium Management
New York
-$163K -20,480 Closed
AFP
60
Ausdal Financial Partners
Iowa
-$94K -11,800 Closed
SF
61
Synovus Financial
Georgia
-$28K -3,500 Closed
SO
62
STRS Ohio
Ohio
-$20K -2,600 Closed
Canada Life
63
Canada Life
Manitoba, Canada
-$8K -1,000 Closed
FDCDDQ
64
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$1.19K -150 Closed
MAM
65
Meeder Asset Management
Ohio
-$1K -135 Closed